心房細動手術の世界市場規模：地域別、範囲および予測

心房細動手術の市場規模と予測

心房細動手術の市場規模は、2023年に25億1,060万米ドルと評価され、2024年から2031年の予測期間中に14.10％のCAGRで成長し、2031年までに72億1,212万米ドルに達すると予測されます。

心房細動手術の世界市場促進要因

心房細動手術市場の市場促進要因は、様々な要因の影響を受ける可能性があります。

心房細動（AF）の有病率：

世界中で、心房細動は人口の高齢化や肥満、糖尿病、高血圧などの危険因子の増加の結果、より一般的になってきています。そのため、手術を含む医療の必要性が高まっています。

技術の進歩：

手術方法，機器，画像技術の進歩により，より安全で効率的な心房細動手術が可能となった。より侵襲の少ない手技やアブレーション技術の向上が患者や医療従事者の関心を集め、市場の拡大を後押ししています。

知識と診断の拡大：

患者や医療従事者は心房細動（AF）に関連する危険性をより認識するようになっており、その結果、早期発見・早期治療が行われるようになっています。心房細動の診断を受ける人が増えるにつれて、心房細動に対する外科的治療の必要性が高まっています。

低侵襲手術の需要：

開腹手術と比較して、患者は回復が早く、入院期間が短く、合併症の少ない低侵襲の治療法をますます求めるようになっています。心房細動の手術が一般的になりつつあるのは、侵襲の少ない手技を求める患者の要望によるものです。

ヘルスケア支出の増加：

世界のヘルスケア支出の増加とインフラ整備の結果、心臓治療、特に心房細動（AF）の外科治療に多くの資金が投入されるようになっています。このような資金投入が市場拡大の原動力となっています。

手術を支持する臨床的証拠：

心房細動に対する外科的治療の安全性と有効性を示す臨床研究が増えるにつれて、患者やヘルスケア専門家が外科的治療を選択する可能性が高まり、市場拡大の原動力となっています。

政府プログラムと支払い規則：

心房細動手術は、心血管疾患の負担を軽減し、ヘルスケアサービスへのアクセスを向上させる政府プログラムによって奨励されています。これらのイニシアチブはまた、有利な支払い規則によっても支えられています。

新興国：

心房細動の有病率が上昇している地域では、新興国の急速な経済成長、ヘルスケアインフラの進歩、ヘルスケア意識の向上により、市場拡大の大きな見込みがあります。

心房細動手術の世界市場抑制要因

心房細動手術市場には、いくつかの要因が市場抑制要因や課題として作用する可能性があります。

高コスト：

心房細動の手術は高額であるため、金銭的余裕のない人々や保険が十分に適用されない人々のアクセスが制限される可能性があります。

リスクと合併症：

心房細動の手術を含め、一般に手術には危険が伴う。出血、感染、周囲の組織や臓器への危害などの合併症があると、患者にとっても医師にとっても手術が敬遠されるかもしれないです。

限られた有効性：

手術は心房細動に対する有効な治療法の1つではあるが、必ずしも長期的な解決につながるとは限らないです。手術後、再び心房細動を発症する人もおり、その場合、患者は不幸な状態になり、さらなる治療が必要となる可能性があります。

技術的な困難

手術結果を改善し，危険性を減少させるためには，手術方法や機器の進歩が必要です。それにもかかわらず、心房細動治療法の有効性は、新しい技術の開発と使用が遅れているために制限されている可能性があります。

代替療法

薬物療法やアブレーションなどのカテーテルを用いた手技は心房細動の管理にしばしば有効です。患者がこれらの治療法を選択したり、医師が推奨したりすれば、外科的手術の必要性は少なくなるかもしれないです。

規制上の障害

新規の手術法や機器に対する長くて厳格な承認手続きは、心房細動手術分野への市場参入や技術革新を妨げる可能性があります。

知識不足：

心房細動患者の多くは、利用可能な手術の選択肢を知らなかったり、自分の病気がどれほど深刻かを見誤ったりすることがあり、そのために必要な援助を受けることを先延ばしにしてしまうことがあります。

訓練と技術：

心房細動の手術には専門的な訓練と技術が必要です。外科的治療を受けられない患者もいます。なぜなら、その地域で外科的治療を行う資格を持った外科医が少ないからです。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 心房細動手術市場：手技別

• カテーテルアブレーション
• 外科手術アブレーション
• メイズ法

第5章 心房細動手術市場、手術アプローチ別

• 低侵襲手術
• 開心術

第6章 心房細動手術市場：エンドユーザー別

• 病院および診療所
• 外来手術センター（ASC）
• 専門心臓センター

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Biosense Webster, Inc.
• Medtronic, Inc.
• St. Jude Medical, Inc.
• Boston Scientific Corporation
• Atricure, Inc.
• Cardiofocus, Inc.
• Ncontact, Inc.
• Carima, Inc.
• Abbott Laboratories
• Johnson & Johnson
• CryoLife, Inc.
• Osypka AG
• BIOTRONIK SE & Co. KG and Biotroik Se & Co.Kg.

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Atrial Fibrillation Surgery Market Size And Forecast

Atrial Fibrillation Surgery Market size was valued at USD 2510.6 Million in 2023 and is projected to reach USD 7212.12 Million by 2031, growing at a CAGR of 14.10% during the forecast period 2024-2031.

Global Atrial Fibrillation Surgery Market Drivers

The market drivers for the Atrial Fibrillation Surgery Market can be influenced by various factors. These may include: Atrial Fibrillation (AF) Prevalence:

Across the globe, AF is becoming more common as a result of an aging population and an increase in risk factors such obesity, diabetes, and hypertension. This raises the need for medical care, including surgery.

Technological Advancements:

Safer and more efficient atrial fibrillation procedures are now possible thanks to advancements in surgical methods, equipment, and imaging technology. Improvements include less intrusive techniques and enhanced ablation technology draw in patients and medical professionals, propelling the market's expansion.

Growing Knowledge and Diagnosis:

Patients and medical professionals are becoming more aware of the dangers connected to atrial fibrillation (AF), which is resulting in early detection and treatment. The need for surgical treatment options for atrial fibrillation (AF) is increasing as more people get the diagnosis.

Demand for Minimally Invasive Procedures:

In comparison to open operations, patients are increasingly looking for minimally invasive treatment options that offer quicker recovery times, shorter hospital stays, and less complications. Atrial fibrillation surgeries are becoming more common due to patient demand for less intrusive procedures.

Growing Healthcare Expenditure:

More funds are being devoted to cardiac care, particularly surgical treatments for atrial fibrillation (AF), as a result of global healthcare expenditure growth and infrastructural improvements. This monetary commitment drives market expansion.

Clinical Evidence in Support of Surgery:

As more clinical research shows the safety and effectiveness of surgical treatments for AF, patients and healthcare professionals are more likely to explore these choices, which propels market expansion.

Government programs and payment rules:

The use of atrial fibrillation surgeries is encouraged by government programs that lower the burden of cardiovascular diseases and increase access to healthcare services. These initiatives are also supported by advantageous payment rules.

Emerging countries:

In areas where the prevalence of AF is rising, there are substantial prospects for market expansion due to the rapid economic growth in emerging countries, as well as the advancement of healthcare infrastructure and raised healthcare awareness.

Global Atrial Fibrillation Surgery Market Restraints

Several factors can act as restraints or challenges for the Atrial Fibrillation Surgery Market. These may include:

High Cost:

Because atrial fibrillation procedures can be costly, access for people who cannot afford them or whose insurance does not cover them adequately may be restricted.

Risk and Complications:

Surgery in general, including atrial fibrillation surgery, carries certain inherent hazards. Surgery might be discouraged by complications such as bleeding, infection, or harm to surrounding tissues or organs for both patients and doctors.

Limited Efficacy:

Although surgery is a viable treatment option for atrial fibrillation, it may not always result in a long-term resolution. After surgery, some individuals may develop atrial fibrillation again, which could leave them unhappy and necessitate additional treatments.

Technological Difficulties:

Improving results and lowering dangers requires advances in surgical methods and equipment. Nevertheless, the effectiveness of atrial fibrillation procedures may be limited by the sluggish development and use of new technologies.

Alternative Therapies:

Medication and catheter-based techniques like ablation are frequently effective in managing atrial fibrillation. There may be less need for surgical procedures if patients choose these options or if doctors advocate them.

Regulatory Obstacles:

Long and rigorous regulatory approval procedures for novel surgical methods or equipment can impede market entry and innovation in the atrial fibrillation surgery space.

Lack of Knowledge:

Many people with atrial fibrillation may not be aware of the surgical alternatives available to them or may misjudge how serious their disease is, which can cause them to put off getting the help they need.

Training and Skill:

Specialized training and skills are needed for atrial fibrillation procedures. Some patients may not be able to receive surgical therapy because there may not be as many qualified surgeons doing these procedures in a given area.

Global Atrial Fibrillation Surgery Market Segmentation Analysis

The Global Atrial Fibrillation Surgery Market is Segmented on the basis of Type of Surgery, Surgical Approach, End-User, and Geography.

Atrial Fibrillation Surgery Market, By Type of Surgery

• Catheter Ablation:
• A minimally invasive procedure where a catheter is inserted through blood vessels to the heart, delivering energy (such as radiofrequency or cryotherapy) to destroy or isolate abnormal electrical pathways causing atrial fibrillation.
• Surgical Ablation:
• Invasive surgical procedures performed in an operating room, involving the creation of scar tissue on the heart's surface (either through open-heart surgery or minimally invasive techniques) to disrupt abnormal electrical signals and restore normal heart rhythm.
• Maze Procedure:
• A type of surgical ablation that creates a series of scar lines on the atria to block abnormal electrical impulses, typically performed during open-heart surgery but may also be done minimally invasively.

Atrial Fibrillation Surgery Market, By Surgical Approach

• Minimally Invasive Surgery:
• Surgical procedures performed through small incisions using specialized instruments and cameras, offering advantages such as reduced postoperative pain, shorter recovery times, and lower risk of complications compared to traditional open-heart surgery.
• Open-Heart Surgery:
• Traditional surgical procedures performed through a sternotomy (opening the chest cavity) to access the heart, allowing for direct visualization and manipulation of cardiac structures, often necessary for complex cases or combined procedures.

Atrial Fibrillation Surgery Market, By End-User

• Hospitals and Clinics:
• Medical facilities equipped with surgical suites and specialized cardiac care units, where atrial fibrillation surgeries are performed by cardiothoracic surgeons and electrophysiologists.
• Ambulatory Surgical Centers (ASCs):
• Outpatient facilities that provide surgical services for atrial fibrillation and other cardiac conditions in a more convenient and cost-effective setting than hospitals, often preferred for minimally invasive procedures.
• Specialty Cardiac Centers:
• Centers of excellence or specialized clinics dedicated to cardiac care, offering comprehensive evaluation, treatment, and follow-up care for patients with atrial fibrillation and other arrhythmias.

Atrial Fibrillation Surgery Market, By Geography

• North America:
• Market dynamics and trends specific to the atrial fibrillation surgery industry in North American regions, including the United States, Canada, and Mexico.
• Europe:
• Market factors and regulatory influences shaping the atrial fibrillation surgery market across European countries such as the UK, Germany, France, and Italy.
• Asia Pacific:
• Growth opportunities and market expansion strategies relevant to atrial fibrillation surgery in countries like China, India, Japan, and South Korea.
• Latin America:
• Market trends and consumer preferences impacting the atrial fibrillation surgery market in Latin American regions like Brazil, Argentina, and Chile.
• Middle East and Africa:
• Factors driving demand for atrial fibrillation surgery in regions like the Middle East and Africa, including increasing prevalence of cardiovascular diseases, improving healthcare infrastructure, and rising adoption of advanced surgical techniques.

Key Players

• The "Global Atrial Fibrillation Surgery Market" study report will provide a valuable insight with an emphasis on the global market including some of the major players such as
• Biosense Webster, Inc., Medtronic, Inc., St. Jude Medical, Inc., Boston Scientific Corporation, Atricure, Inc., Cardiofocus, Inc., Ncontact, Inc., Carima, Inc., Abbott Laboratories, Johnson & Johnson, CryoLife, Inc., Osypka AG, BIOTRONIK SE & Co. KG and Biotroik Se & Co.Kg.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Atrial Fibrillation Surgery Market, By Type of Surgery

• Catheter Ablation
• Surgical Ablation
• Maze Procedure

5. Atrial Fibrillation Surgery Market, By Surgical Approach

• Minimally Invasive Surgery
• Open-Heart Surgery

6. Atrial Fibrillation Surgery Market, By End-User

• Hospitals and Clinics
• Ambulatory Surgical Centers (ASCs)
• Specialty Cardiac Centers

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Biosense Webster, Inc.
• Medtronic, Inc.
• St. Jude Medical, Inc.
• Boston Scientific Corporation
• Atricure, Inc.
• Cardiofocus, Inc.
• Ncontact, Inc.
• Carima, Inc.
• Abbott Laboratories
• Johnson & Johnson
• CryoLife, Inc.
• Osypka AG
• BIOTRONIK SE & Co. KG and Biotroik Se & Co.Kg.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References